Literature DB >> 20041441

Defective interfering viruses and their potential as antiviral agents.

A C Marriott1, N J Dimmock.   

Abstract

Defective interfering (DI) virus is simply defined as a spontaneously generated virus mutant from which a critical portion of the virus genome has been deleted. At least one essential gene of the virus is deleted, either in its entirety, or sufficiently to make it non-functional. The resulting DI genome is then defective for replication in the absence of the product(s) of the deleted gene(s), and its replication requires the presence of the complete functional virus genome to provide the missing functions. In addition to being defective DI virus suppresses production of the helper virus in co-infected cells, and this process of interference can readily be observed in cultured cells. In some cases, DI virus has been observed to attenuate disease in virus-infected animals. In this article, we review the properties of DI virus, potential mechanisms of interference and progress in using DI virus (in particular that derived from influenza A virus) as a novel type of antiviral agent.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20041441     DOI: 10.1002/rmv.641

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  63 in total

1.  Evaluation of perceived threat differences posed by filovirus variants.

Authors:  Jens H Kuhn; Lori E Dodd; Victoria Wahl-Jensen; Sheli R Radoshitzky; Sina Bavari; Peter B Jahrling
Journal:  Biosecur Bioterror       Date:  2011-11-09

2.  RNA-mediated interference and reverse transcription control the persistence of RNA viruses in the insect model Drosophila.

Authors:  Bertsy Goic; Nicolas Vodovar; Juan A Mondotte; Clément Monot; Lionel Frangeul; Hervé Blanc; Valérie Gausson; Jorge Vera-Otarola; Gael Cristofari; Maria-Carla Saleh
Journal:  Nat Immunol       Date:  2013-02-24       Impact factor: 25.606

3.  Identification of RNA partners of viral proteins in infected cells.

Authors:  Anastassia V Komarova; Chantal Combredet; Odile Sismeiro; Marie-Agnès Dillies; Bernd Jagla; Raul Yusef Sanchez David; Nicolas Vabret; Jean-Yves Coppée; Pierre-Olivier Vidalain; Frédéric Tangy
Journal:  RNA Biol       Date:  2013-04-01       Impact factor: 4.652

Review 4.  Emergency Services of Viral RNAs: Repair and Remodeling.

Authors:  Vadim I Agol; Anatoly P Gmyl
Journal:  Microbiol Mol Biol Rev       Date:  2018-03-14       Impact factor: 11.056

5.  Effects of defective interfering RNA on symptom induction by, and replication of, a novel partitivirus from a phytopathogenic fungus, Rosellinia necatrix.

Authors:  Sotaro Chiba; Yu-Hsin Lin; Hideki Kondo; Satoko Kanematsu; Nobuhiro Suzuki
Journal:  J Virol       Date:  2012-12-12       Impact factor: 5.103

6.  Molecular characterization of Drosophila cells persistently infected with Flock House virus.

Authors:  Juan Jovel; Anette Schneemann
Journal:  Virology       Date:  2011-08-26       Impact factor: 3.616

7.  T-705 (favipiravir) induces lethal mutagenesis in influenza A H1N1 viruses in vitro.

Authors:  Tatiana Baranovich; Sook-San Wong; Jianling Armstrong; Henju Marjuki; Richard J Webby; Robert G Webster; Elena A Govorkova
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

8.  Design requirements for interfering particles to maintain coadaptive stability with HIV-1.

Authors:  Igor M Rouzine; Leor S Weinberger
Journal:  J Virol       Date:  2012-12-05       Impact factor: 5.103

9.  1918 Influenza receptor binding domain variants bind and replicate in primary human airway cells regardless of receptor specificity.

Authors:  A Sally Davis; Daniel S Chertow; Jason Kindrachuk; Li Qi; Louis M Schwartzman; Jon Suzich; Sara Alsaaty; Carolea Logun; James H Shelhamer; Jeffery K Taubenberger
Journal:  Virology       Date:  2016-04-11       Impact factor: 3.616

10.  Towards multiscale modeling of influenza infection.

Authors:  Lisa N Murillo; Michael S Murillo; Alan S Perelson
Journal:  J Theor Biol       Date:  2013-04-19       Impact factor: 2.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.